RedHill Biopharma Ltd.

RDHL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$8$24-$72-$98
Dep. & Amort.$1$2$8$18
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$2$6$10
Change in WC$2-$16$8-$1
Other Non-Cash-$4-$48$21$5
Operating Cash Flow-$9-$36-$29-$65
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$8
Inv. Purchases$0$0$0-$9
Inv. Sales/Matur.$0$0$9$0
Other Inv. Act.$0$0$0-$8
Investing Cash Flow-$0$0$8-$8
Financing Activities
Debt Repay.-$1-$1-$1-$2
Stock Issued$8$14$24$79
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$9-$11-$3
Financing Cash Flow$8$21$11$73
Forex Effect$0-$0-$0-$0
Net Chg. in Cash-$1-$14-$10$0
Supplemental Information
Beg. Cash$6$20$29$29
End Cash$5$6$20$29
Free Cash Flow-$9-$36-$29-$65